J E Lehr

796 total citations
12 papers, 621 citations indexed

About

J E Lehr is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J E Lehr has authored 12 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J E Lehr's work include Cancer, Hypoxia, and Metabolism (2 papers), Prostate Cancer Treatment and Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). J E Lehr is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Prostate Cancer Treatment and Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). J E Lehr collaborates with scholars based in United States and South Korea. J E Lehr's co-authors include Kenneth J. Pienta, S Whitney, Susan Korenchuk, Lisa L. McLean, R L Vessella, Din L. Lin, Adil Akhtar, Larry Tait, Kazuto Yamazaki and Victor Hogan and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Radiology and Otolaryngology.

In The Last Decade

J E Lehr

12 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J E Lehr United States	7	309	222	146	127	104	12	621
Chunpeng Zhang China	15	681 2.2×	208 0.9×	82 0.6×	200 1.6×	64 0.6×	23	938
Michael Carducci United States	13	436 1.4×	85 0.4×	39 0.3×	149 1.2×	88 0.8×	24	707
Gonzalo Rodríguez‐Berriguete Spain	17	368 1.2×	184 0.8×	81 0.6×	158 1.2×	51 0.5×	22	623
Keiko Shoji Japan	10	361 1.2×	65 0.3×	48 0.3×	97 0.8×	50 0.5×	20	657
Omar Rahal United States	12	331 1.1×	54 0.2×	96 0.7×	200 1.6×	105 1.0×	20	623
Kazuhiro Maejima Japan	16	684 2.2×	136 0.6×	80 0.5×	229 1.8×	79 0.8×	39	1.0k
Weixi Shen China	14	181 0.6×	138 0.6×	58 0.4×	155 1.2×	24 0.2×	28	580
Jiateng Zhong China	13	415 1.3×	112 0.5×	163 1.1×	235 1.9×	29 0.3×	36	771
Shuyun Rao United States	13	526 1.7×	79 0.4×	65 0.4×	157 1.2×	47 0.5×	24	722
Y C Wong Hong Kong	13	385 1.2×	44 0.2×	55 0.4×	223 1.8×	71 0.7×	14	681

Countries citing papers authored by J E Lehr

Since Specialization

Citations

This map shows the geographic impact of J E Lehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J E Lehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J E Lehr more than expected).

Fields of papers citing papers by J E Lehr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J E Lehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J E Lehr. The network helps show where J E Lehr may publish in the future.

Co-authorship network of co-authors of J E Lehr

This figure shows the co-authorship network connecting the top 25 collaborators of J E Lehr. A scholar is included among the top collaborators of J E Lehr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J E Lehr. J E Lehr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Korenchuk, Susan, et al.. (2001). Establishment and characterization of a new human prostatic cancer cell line: DuCaP.. PubMed. 15(2). 157–62. 38 indexed citations

2.

Korenchuk, Susan, J E Lehr, Lisa L. McLean, et al.. (2001). VCaP, a cell-based model system of human prostate cancer.. PubMed. 15(2). 163–8. 250 indexed citations

3.

Yee, Christina, et al.. (1998). The effect of castanospermine on the metastatic properties of prostate cancer cells.. PubMed. 17(5A). 3659–63. 8 indexed citations

4.

Lehr, J E, et al.. (1998). A model to study c-myc and v-H-ras induced prostate cancer progression in the Copenhagen rat.. PubMed. 44(6). 949–59. 4 indexed citations

5.

Pilat, Mary Jo, et al.. (1998). The effect of amiloride on the metastatic properties of prostate cancer in the Dunning rat model.. Oncology Reports. 5(4). 889–92. 2 indexed citations

6.

Yamazaki, Kazuko, et al.. (1996). Establishment of immortalized Copenhagen rat prostate endothelial cell lines.. PubMed. 9(5). 421–6. 4 indexed citations

7.

Sakr, Wael, et al.. (1996). Unique Nuclear Matrix Protein Alterations in Head and Neck Squamous Cell Carcinomas: Intermediate Biomarker Candidates. Otolaryngology. 114(3). 387–393. 19 indexed citations

8.

Pienta, Kenneth J., Adil Akhtar, Kazuto Yamazaki, et al.. (1995). Inhibition of Spontaneous Metastasis in a Rat Prostate Cancer Model by Oral Administration of Modified Citrus Pectin. JNCI Journal of the National Cancer Institute. 87(5). 348–353. 215 indexed citations

9.

Petrylak, Daniel P., et al.. (1995). PRECLINICAL STUDIES OF GOSSYPOL IN PROSTATE CARCINOMA. International Journal of Oncology. 6(1). 209–13. 6 indexed citations

10.

Lehr, J E, et al.. (1995). An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer.. PubMed. 14(6B). 2617–9. 62 indexed citations

11.

Lehr, J E, et al.. (1995). Oral cyclophosphamide and oral hydroxyurea in the treatment of hormone refractory prostate cancer in rats.. PubMed. 14(6B). 2681–4. 2 indexed citations

12.

Hofer, K. G., et al.. (1981). Radiosensitization of tumors and normal tissues by combined treatment with misonidazole and heat.. Radiology. 141(3). 801–809. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact